Clinical laboratories frequently encounter sample pad blood filtration challenges when validating Lateral Flow assays. Glass fiber retains 95% RBCs but releases 20% in plasma. This technical guide consolidates troubleshooting data from field validation studies and explains the measurement parameters that affect reproducibility.
Fiber type
Validation studies demonstrate that fiber type significantly affects sample pad blood filtration performance. Glass fiber retains 95% RBCs but releases 20% in plasma This technical parameter requires verification across multiple reagent lots before commercial deployment. Suppliers should provide coefficient of variation data (CV <15% acceptable) and stability studies demonstrating consistent performance over the intended shelf life.
Blood cell retention
Validation studies demonstrate that blood cell retention significantly affects sample pad blood filtration performance. Glass fiber retains 95% RBCs but releases 20% in plasma This technical parameter requires verification across multiple reagent lots before commercial deployment. Suppliers should provide coefficient of variation data (CV <15% acceptable) and stability studies demonstrating consistent performance over the intended shelf life.
Plasma release rate
Validation studies demonstrate that plasma release rate significantly affects sample pad blood filtration performance. Glass fiber retains 95% RBCs but releases 20% in plasma This technical parameter requires verification across multiple reagent lots before commercial deployment. Suppliers should provide coefficient of variation data (CV <15% acceptable) and stability studies demonstrating consistent performance over the intended shelf life.
Frequently Asked Questions
What causes sample pad blood filtration variation across production lots?
Manufacturing inconsistencies in fiber type are the primary cause. Glass fiber retains 95% RBCs but releases 20% in plasma Quality control protocols should include lot-to-lot comparison testing with reference samples.
How should labs validate sample pad blood filtration before routine use?
Run at least 3 independent experiments with positive and negative controls. Measure key parameters and compare results to manufacturer specifications. Document any deviations for troubleshooting.
Distributor Evaluation Checklist
- Request sample pad blood filtration validation data from supplier (minimum 3 independent lots)
- Verify sample pad blood filtration specifications match published literature for Lateral Flow
- Perform side-by-side comparison with reference method or gold standard
- Document sample pad blood filtration performance under intended use conditions (temperature, sample type)